Syngene International IPO – Should you invest? Biocon subsidiary, Syngene International IPO would open for subscription on 27th July, 2015. Syngene offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology, in vivo pharmacology and toxicology. Should you invest in this Syngene International Limited IPO? What are the risk factors to be … Continue reading Syngene International IPO – Should you invest?